SQUAWK/NEWS
Menu
Live News EQUITY L impact

Morning Movers: Ionis and AstraZeneca sink after trial misses endpoint

Morning Movers: Ionis and AstraZeneca sink after trial misses endpoint

APSMPLTFPM

Morning Movers: Ionis and AstraZeneca sink after trial misses endpoint